Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 16/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CTSL | P07711 | 3/20 | 0.51 |
| ▸ | CTSB | P07858 | 3/20 | 0.51 |
| ▸ | CTSH | P09668 | 1/20 | 0.46 |
| ▸ | SYK | P43405 | 1/20 | 0.45 |
| ▸ | KLK7 | P49862 | 1/20 | 0.45 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4821212 | 0.88 | MAPT (0.66) | CTSKMAPTCTSLCTSBSYK | |
| SCHEMBL8311926 | 0.88 | CTSK (0.56) | CTSKMAPTCTSLCTSBCTSH | |
| SCHEMBL21904603 | 0.87 | PPARA (0.53) | CTSKMAPTKLK7KLK5 | |
| SCHEMBL699601 | 0.85 | MAPT (0.61) | CTSKMAPTCTSLCTSBSYK | |
| SCHEMBL12247705 | 0.85 | MAPT (0.61) | CTSKMAPTCTSLCTSBSYK | |
| SCHEMBL23156912 | 0.84 | CTSK (0.50) | CTSKMAPTCTSLCTSBSYK | |
| SCHEMBL4179699 | 0.84 | MAPT (0.62) | CTSKMAPTCTSLCTSBCTSH | |
| SCHEMBL28516961 | 0.84 | CTSK (0.57) | CTSKMAPTCTSLCTSBCTSH | |
| SCHEMBL7975866 | 0.82 | KLK5 (0.52) | CTSKMAPTCTSLCTSBSYK | |
| SCHEMBL23971349 | 0.82 | KLK5 (0.52) | CTSKMAPTCTSLCTSBSYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210163541-A1 | Method for Preparing PNA Oligomer | SEASUNBIO MATERIALS (KR) | 2021-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163541-A1 | Method for Preparing PNA Oligomer | NCL, NOD1, POLI | CTSK 4075/4885MAPT 2234/4885CTSL 2953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.